Photocure ASA: Results for the third quarter of 2023

/PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 107.3 million in the third quarter of 2023 (Q3 2022: NOK 96.9 million),...

Related Keywords

China ,Oslo ,Norway ,Norwegian ,Erik Dahl ,Karl Storz ,Hexvix Cysview ,Dan Schneider ,David Moskowitz ,Tolv Hillestad ,Prnewswire Photocure ,Corporate Communications Norway ,Oslo Stock Exchange ,Stryker Corporation ,Bladder Cancer Company ,Chief Executive Officer ,Blue Light Cystoscopy ,Abuse Regulation ,Norwegian Securities Trading ,Group Controller ,Photocure ,